Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5503933 | 0.93 | MAPT (0.70) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL5712810 | 0.91 | MAPT (0.65) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL5712873 | 0.90 | MEN1 (0.64) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL6998940 | 0.90 | MEN1 (0.63) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL6992785 | 0.90 | MAPT (0.63) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL7001450 | 0.88 | KMT2A (0.61) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL6994209 | 0.87 | MAPT (0.60) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL19475110 | 0.87 | MAPT (0.72) | KMT2AMEN1MAPTGAAALDH1A1 | |
| SCHEMBL5712840 | 0.82 | ADORA1 (0.76) | KMT2AMEN1MAPTKDM4ETDP1 | |
| SCHEMBL5506528 | 0.79 | GAA (0.66) | KMT2AMEN1MAPTGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1671973-A2 | Allosteric adenosine receptor modulators | King Pharmaceuticals Research and Development, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1025106-B1 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | KING PHARMACEUTICALS RES & DEV (US) | 2006-06-21 | — | — | EP | claimed |
| US-6177444-B1 | ANTIISCHEMIC AGENTS; ANTIARRHYTHMIA AGENTS | MEDCO CORP. | 2001-01-23 | — | — | US | claimed |
| EP-1025106-A2 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | Medco Research, Inc. (US) | 2000-08-09 | — | — | EP | claimed |
| WO-1999021617-B1 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | MEDCO RES INC (US) | 1999-09-10 | — | — | WO | claimed |
| WO-1999021617-A2 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | MEDCO RESEARCH, INC. (US) | 1999-05-06 | — | — | WO | claimed |
| EP-1390740-A4 | METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A 1? ADENOSINE RECEPTOR LIGANDS FOR THE A 1? ADENOSINE RECEPTOR | ENDACEA INC (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-1671973-A2 | Allosteric adenosine receptor modulators | King Pharmaceuticals Research and Development, Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1025106-B1 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | KING PHARMACEUTICALS RES & DEV (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20040121406-A1 | Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor | ENDACEA, INC. | 2004-06-24 | — | — | US | disclosed |
| EP-1390740-A1 | METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A 1? ADENOSINE RECEPTOR LIGANDS FOR THE A 1? ADENOSINE RECEPTOR | Endacea, Inc. (US) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002095391-A1 | METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A1 ADENOSINE RECEPTOR LIGANDS FOR THE A1 ADENOSINE RECEPTOR | ENDACEA INC. (US) | 2002-11-28 | — | — | WO | disclosed |
| US-6323214-B1 | CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS AND ANALGESICS | MEDCO RESEARCH, INC | 2001-11-27 | — | — | US | disclosed |
| US-6194449-B1 | ADMINISTERING A BENZOYLTHIOPHENE COMPOUND; ANTIHYPOXIC, ANTIISCHEMIC AGENTS | MEDCO CORP. | 2001-02-27 | — | — | US | disclosed |
| US-6177444-B1 | ANTIISCHEMIC AGENTS; ANTIARRHYTHMIA AGENTS | MEDCO CORP. | 2001-01-23 | — | — | US | disclosed |
| EP-1025106-A2 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | Medco Research, Inc. (US) | 2000-08-09 | — | — | EP | disclosed |
| US-5939432-A | Thiophenes useful for modulating the adenosine receptor | MEDCO RESEARCH, INC. (US) | 1999-08-17 | — | — | US | disclosed |
| WO-1999021617-A2 | ALLOSTERIC ADENOSINE RECEPTOR MODULATORS | MEDCO RESEARCH, INC. (US) | 1999-05-06 | — | — | WO | disclosed |